Skip to content

To screen or not to screen? When it comes to prostate and breast cancers, that's still the question

Mixed signals abound surrounding screenings for prostate and breast cancers. Should we only screen patients in high-risk populations? At what age should screenings begin, and how often should they be done? Are we screening too much or not enough?

On KQED’s Forum this morning, Stanford urologic cancer expert Mark Gonzalgo, MD, PhD, expressed what has emerged as a popular answer to these questions: Screening should be individualized, based on a shared decision-making  approach between physician and patient. Gonzalgo was joined on the panel by UCSF researcher Jeff Belkora, PhD; surgeon Susan Kutner, MD, chair of Kaiser Permanente Northern California’s Breast Care Task Force, and Richard Knox, NPR's science desk correspondent; their conversation is worth a listen.

Popular posts

Sex biology redefined: Genes don’t indicate binary sexes

The scenario many of us learned in school is that two X chromosomes make someone female, and an X and a Y chromosome make someone male. These are simplistic ways of thinking about what is scientifically very complex.
Intermittent fasting: Fad or science-based diet?

Are the health-benefit claims from intermittent fasting backed up by scientific evidence? John Trepanowski, postdoctoral research fellow at the Stanford Prevention Research Center,weighs in.